Novo Nordisk Pharmatech lands record profits in 2020

Novo Nordisk-owned company Novo Nordisk Pharmatech landed record profits in 2020. The firm's soon-to-be-former managing director reasons that this owes to solid advances in two product groups in particular.
Novo Nordisk Pharmatech Managing Director Rasmus Hother le Fevre | Photo: Gregers Tycho/ERH
Novo Nordisk Pharmatech Managing Director Rasmus Hother le Fevre | Photo: Gregers Tycho/ERH
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN

Novo Nordisk' supply-focused subsidiary Novo Nordisk Pharmatech came out of 2020 with a record profit, according to the 2020 annual financial report for the latter.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading